Pharmacological Reports

4.1(top 10%)

impact factor

2.9K(top 10%)

papers

59.8K(top 5%)

citations

85(top 10%)

h-index

4.2(top 10%)

extended IF

3.9K

all documents

63.1K

doc citations

141(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	A review on Alzheimer's disease pathophysiology and its management: an update	Pharmacological Reports	2015	1,181
2	Nanoparticles as drug delivery systems	Pharmacological Reports	2012	1,001
3	Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron	Pharmacological Reports	2009	633
4	ICAM-1 signaling in endothelial cells	Pharmacological Reports	2009	534
5	Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists	Pharmacological Reports	2007	438
6	Age-related macular degeneration (AMD): pathogenesis and therapy	Pharmacological Reports	2006	408
7	Therapeutic strategies for Alzheimer's disease in clinical trials	Pharmacological Reports	2016	357
8	Lipoic acid – biological activity and therapeutic potential	Pharmacological Reports	2011	336
9	Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide	Pharmacological Reports	2010	323
10	Drug repurposing approach to fight COVID-19	Pharmacological Reports	2020	323
11	Treatment of inflammatory bowel disease (IBD)	Pharmacological Reports	2011	288
12	COX-2 as a target for cancer chemotherapy	Pharmacological Reports	2010	278
13	Physiology and pharmacology of melatonin in relation to biological rhythms	Pharmacological Reports	2009	257
14	Lipoic acid - the drug of the future?	Pharmacological Reports	2005	244
15	Antihypertensive effects of the flavonoid quercetin	Pharmacological Reports	2009	243
16	Role of NF-κB in the pathogenesis of diabetes and its associated complications	Pharmacological Reports	2009	227
17	Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes	Pharmacological Reports	2012	212
18	Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism	Pharmacological Reports	2015	212
19	The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment	Pharmacological Reports	2017	207
20	Early maternal separation: a rodent model of depression and a prevailing human condition	Pharmacological Reports	2013	201
21	Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development	Pharmacological Reports	2006	200
22	Animal models of acute renal failure	Pharmacological Reports	2012	196
23	Anti-inflammatory and side effects of cyclooxygenase inhibitors	Pharmacological Reports	2007	195
24	Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment	Pharmacological Reports	2009	183
25	Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems	Pharmacological Reports	2013	181
26	Prodrugs: A challenge for the drug development	Pharmacological Reports	2013	177
27	Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions	Pharmacological Reports	2009	175
28	Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system	Pharmacological Reports	2009	167
29	Chemical structure of phenothiazines and their biological activity	Pharmacological Reports	2012	165
30	Biochemical and pharmacological characterization of isatin and its derivatives: from structure to activity	Pharmacological Reports	2013	164
31	Berberine and neurodegeneration: A review of literature	Pharmacological Reports	2015	161
32	Tropane alkaloids as medicinally useful natural products and their synthetic derivatives as new drugs	Pharmacological Reports	2008	156
33	Statin-induced myopathies	Pharmacological Reports	2011	155
34	Physiology and pharmacological role of the blood-brain barrier	Pharmacological Reports	2008	152
35	Cytochrome P450–dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids	Pharmacological Reports	2010	150
36	Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness	Pharmacological Reports	2008	147
37	Endothelium in health and disease	Pharmacological Reports	2008	146
38	Vitamin D and the central nervous system	Pharmacological Reports	2013	143
39	Statins: a new insight into their mechanisms of action and consequent pleiotropic effects	Pharmacological Reports	2007	142
40	A review on antioxidant potential of bioactive heterocycle benzofuran: Natural and synthetic derivatives	Pharmacological Reports	2017	140
41	Regulation of sphingomyelin metabolism	Pharmacological Reports	2016	135
42	Prostacyclin among prostanoids	Pharmacological Reports	2008	133
43	Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats	Pharmacological Reports	2005	132
44	Neuroprotective potential of three neuropeptides PACAP, VIP and PHI	Pharmacological Reports	2005	132
45	Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis	Pharmacological Reports	2011	130
46	Tramadol as an analgesic for mild to moderate cancer pain	Pharmacological Reports	2009	129
47	Scavenging and antioxidant potential of physiological taurine concentrations against different reactive oxygen/nitrogen species	Pharmacological Reports	2010	128
48	Endothelial dysfunction in heart failure	Pharmacological Reports	2008	127
49	Hydrogen sulfide in pharmacology and medicine – An update	Pharmacological Reports	2015	124
50	Essential elements in depression and anxiety. Part I	Pharmacological Reports	2014	122

Scientometrics

Overviews

Citing Bodies

Pharmacological Reports

Top Articles